#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Kevin Daly Email
SVP, Device Development & Regulatory Affairs . CXL Ophthalmics
How to contact Kevin Daly
Join and see Kevin's contact info for free!Current Roles
Employees:
8Revenue:
$804kAbout
CXL Ophthalmics (CXLO) is developing innovative treatments for corneal diseases with the goal of saving and improving vision for millions of patients around the world. EpiSmart, its transformative cross-linking system targeting keratoconus, a common type of corneal ectasia, is designed to be minimally invasive with reduced discomfort and a significantly reduced recovery time versus current standards of care. CXLO’s elegant approach will elevate the standard of care by enabling the treatment of both eyes simultaneously and eliminating the need for further deterioration. With a true Epi-On approach that does not disrupt the epithelium, CXLO is striving to deliver safer and more accessible vision-preserving care to millions of patients globally.CXL Ophthalmics Address
4354 Manchester Avenuenull, null